These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11311470)
21. Platelet-derived growth factor (PDGF) and receptor (PDGFR) expression in human meningiomas: correlations with clinicopathological features and cytogenetic analysis. Figarella-Branger D; Vagner-Capodano AM; Bouillot P; Graziani N; Gambarelli D; Devictor B; Zattara-Cannoni H; Bianco N; Grisoli F; Pellissier JF Neuropathol Appl Neurobiol; 1994 Oct; 20(5):439-47. PubMed ID: 7531297 [TBL] [Abstract][Full Text] [Related]
22. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression. Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298 [TBL] [Abstract][Full Text] [Related]
23. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas. Lin YW; Tai SH; Huang YH; Chang CC; Juan WS; Chao LC; Wen MJ; Hung YC; Lee EJ Cytometry B Clin Cytom; 2015; 88(5):312-9. PubMed ID: 25408130 [TBL] [Abstract][Full Text] [Related]
24. MIB-1 staining index of pediatric meningiomas. Sandberg DI; Edgar MA; Resch L; Rutka JT; Becker LE; Souweidane MM Neurosurgery; 2001 Mar; 48(3):590-5; discussion 595-7. PubMed ID: 11270550 [TBL] [Abstract][Full Text] [Related]
25. Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature. Strojan P; Popović M; Jereb B Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):65-73. PubMed ID: 10924973 [TBL] [Abstract][Full Text] [Related]
26. Morphometrical analysis of nucleolin immunohistochemistry in meningiomas. Ohkoudo M; Sawa H; Shiina Y; Sato H; Kamata K; Iijima J; Yamamoto H; Fujii M; Saito I Acta Neuropathol; 1996 Jul; 92(1):1-7. PubMed ID: 8811118 [TBL] [Abstract][Full Text] [Related]
27. Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labelling and immunohistochemical study. Ng HK; Chen L Histopathology; 1998 Jul; 33(1):64-70. PubMed ID: 9726051 [TBL] [Abstract][Full Text] [Related]
28. [Meningiomas: new prognostic factors]. Sanz Esponera J An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599 [TBL] [Abstract][Full Text] [Related]
30. A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression. Murakami M; Hashimoto N; Takahashi Y; Hosokawa Y; Inazawa J; Mineura K Cancer Genet Cytogenet; 2003 Jan; 140(2):99-106. PubMed ID: 12645646 [TBL] [Abstract][Full Text] [Related]
31. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670 [TBL] [Abstract][Full Text] [Related]
32. Masked hypodiploidy in anaplastic meningiomas by duplication of the original clone found in atypical meningiomas: illustration of the evolution of genetic alterations. Ely EE; Guzman MA; Calvey LS; Batanian JR Neuropathology; 2014 Aug; 34(4):353-9. PubMed ID: 24612240 [TBL] [Abstract][Full Text] [Related]
33. PS6K amplification characterizes a small subset of anaplastic meningiomas. Cai DX; James CD; Scheithauer BW; Couch FJ; Perry A Am J Clin Pathol; 2001 Feb; 115(2):213-8. PubMed ID: 11211609 [TBL] [Abstract][Full Text] [Related]
34. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas. Donnini S; Machein MR; Plate KH; Weich HA J Pathol; 1999 Sep; 189(1):66-71. PubMed ID: 10451490 [TBL] [Abstract][Full Text] [Related]
35. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations]. Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of proliferation index and expression of the RNA component of human telomerase (hTR) in papillary meningiomas. Rushing EJ; Colvin SM; Gazdar A; Miura N; White CL; Coimbra C; Burns DK J Neurooncol; 1999; 45(3):199-207. PubMed ID: 10845390 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II. Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806 [TBL] [Abstract][Full Text] [Related]
38. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430 [TBL] [Abstract][Full Text] [Related]
39. Expression of merlin, NDRG2, ERBB2, and c-MYC in meningiomas: relationship with tumor grade and recurrence. Ongaratti BR; Silva CB; Trott G; Haag T; Leães CG; Ferreira NP; Oliveira MC; Pereira-Lima JF Braz J Med Biol Res; 2016; 49(4):e5125. PubMed ID: 27007654 [TBL] [Abstract][Full Text] [Related]
40. Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Nakasu S; Li DH; Okabe H; Nakajima M; Matsuda M Am J Surg Pathol; 2001 Apr; 25(4):472-8. PubMed ID: 11257621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]